Get started
Award

82300526

Funded outputs count: 20
Funder award ID: 82300526
OpenAlex ID: G762525017
SIRT1–Redox Crosstalk in Aging: Adaptive Capacity and Cellular State Transitions
2026 · Mengting Yan, Linrui Hua, et al. · Biology
Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis
2026 · Yuxin Wei, Fengmei Zhang, et al. · Frontiers in Immunology
PDF
Calcium imbalance drives organelle network collapse and immune remodeling: novel pathogenic mechanisms in MASLD progression
2026 · Senping Xu, Ziyang Jiang, et al. · Frontiers in Immunology · 2
PDF
SASP-mediated cellular senescence following myocardial infarction: from spatiotemporal immune regulation to therapeutic strategies
2026 · Fengmei Zhang, Yuanpeng Liao, et al. · Frontiers in Immunology
PDF
CT-based immune radiomic signature for prognosis and prediction of immunotherapy and anticancer drug response in NSCLC
2026 · Jianying Ma, Kaixing Guo, et al. · Frontiers in Immunology
PDF
Pathological mechanisms and research progress of multilevel intervention therapy for coronary heart disease
2026 · Zhengyu Tu, Yuxin Wei, et al. · Frontiers in Immunology · 2
PDF
The cardiovascular-immune axis: crosstalk and therapy in atherosclerosis, myocarditis and vasculitis
2026 · Yuan-peng Liao, Yu-xin Wei, et al. · Frontiers in Immunology · 4
PDF
Immune Determinants of MASLD Progression: From Immunometabolic Reprogramming to Fibrotic Transformation
2026 · Senping Xu, Zhaoshan Zhang, et al. · Biology · 9
PDF
Macrophage polarization in acute myocardial infarction: multidimensional regulation and emerging therapeutic opportunities
2026 · Zilv Ye, Bo Wang, et al. · Frontiers in Immunology · 9
PDF
Innovative Experimental Teaching in Medical Education: Integrating Inquiry-Based Learning and Value Education
2026 · Jiawei Guo · Open Journal of Applied Sciences
PDF
Immune-mediated blood-brain barrier disruption after ischemic stroke: mechanisms and therapeutic targets
2025 · Hanjing Wang, Zhang Yiqiang, et al. · Frontiers in Immunology · 35
PDF
Post-translational modifications orchestrate mTOR-driven cell death in cardiovascular disease
2025 · Jiawei Guo, Yiting Wu, et al. · Frontiers in Cardiovascular Medicine · 2
PDF
Targeting NADPH oxidase-driven oxidative stress in diabetic cardiomyopathy: mechanisms and therapeutic perspectives
2025 · Zilv Ye, Sutong Wang, et al. · Frontiers in Pharmacology · 17
PDF
Macrophage CBX4 Potentiates Atherosclerosis by its SUMO E3 Ligase Activity
2025 · Zhenyu Zhao, Senping Xu, et al. · Cardiovascular Drugs and Therapy · 2
Molecular Insights into Oxidative-Stress-Mediated Cardiomyopathy and Potential Therapeutic Strategies
2025 · Zhenyu Xiong, Yuanpeng Liao, et al. · Biomolecules · 26
PDF
The interplay of ferroptosis and oxidative stress in the pathogenesis of aortic dissection
2025 · Zhaoshan Zhang, Haichao Wang, et al. · Frontiers in Pharmacology · 14
PDF
Macrophage pyroptosis in atherosclerosis: therapeutic potential
2025 · Jianying Ma, Yixian Wang, et al. · Acta Biochimica et Biophysica Sinica · 7
PDF
Deciphering Oxidative Stress in Cardiovascular Disease Progression: A Blueprint for Mechanistic Understanding and Therapeutic Innovation
2024 · Zhaoshan Zhang, Jiawei Guo · Antioxidants · 40
PDF
Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice
2024 · Zhaowei Zou, Xiu Liu, et al. · Journal of Hepatology · 34
Ferroptosis: a potential target for the treatment of atherosclerosis
2024 · Chengyi Li, Ran Liu, et al. · Acta Biochimica et Biophysica Sinica · 25
PDF
Year
Topic